Engineered chimeric peptides with antimicrobial and titanium-binding functions to inhibit biofilm formation on Ti implants

Mater Sci Eng C Mater Biol Appl. 2018 Jan 1:82:141-154. doi: 10.1016/j.msec.2017.08.062. Epub 2017 Aug 18.

Abstract

Titanium (Ti) implants have been commonly used in oral medicine. However, despite their widespread clinical application, these implants are susceptible to failure induced by microbial infection due to bacterial biofilm formation. Immobilization of chimeric peptides with antibacterial properties on the Ti surface may be a promising antimicrobial approach to inhibit biofilm formation. Here, chimeric peptides were designed by connecting three sequences (hBD-3-1/2/3) derived from human β-defensin-3 (hBD-3) with Ti-binding peptide-l (TBP-l: RKLPDAGPMHTW) via a triple glycine (G) linker to modify Ti surfaces. Using X-ray photoelectron spectroscopy (XPS), the properties of individual domains of the chimeric peptides were evaluated for their binding activity toward the Ti surface. The antimicrobial and anti-biofilm efficacy of the peptides against initial settlers, Streptococcus oralis (S. oralis), Streptococcus gordonii (S. gordonii) and Streptococcus sanguinis (S. sanguinis), was evaluated with confocal laser scanning microscopy (CLSM) and scanning electron microscopy (SEM). Transmission electron microscopy (TEM) and real-time quantitative PCR (qRT-PCR) were used to study cell membrane changes and the underlying antimicrobial mechanism. Compared with the other two peptides, TBP-1-GGG-hBD3-3 presented stronger antibacterial activity and remained stable in saliva and serum. Therefore, it was chosen as the best candidate to modify Ti surfaces in this study. This peptide inhibited the growth of initial streptococci and biofilm formation on Ti surfaces with no cytotoxicity to MC3T3-E1 cells. Disruption of the integrity of bacterial membranes and decreased expression of adhesion protein genes from S. gordonii revealed aspects of the antibacterial mechanism of TBP-1-GGG-hBD3-3. We conclude that engineered chimeric peptides with antimicrobial activity provide a potential solution for inhibiting biofilm formation on Ti surfaces to reduce or prevent the occurrence of peri-implant diseases.

Keywords: Antimicrobial peptides; Chimeric peptides; Human β-defensin-3; Peri-implantitis; Titanium surface modification; Titanium-binding peptide.

MeSH terms

  • Anti-Infective Agents / chemistry*
  • Anti-Infective Agents / pharmacology*
  • Biofilms / drug effects
  • Cell Line
  • Humans
  • Microscopy, Confocal
  • Microscopy, Electron, Transmission
  • Peptides / chemistry*
  • Streptococcus gordonii / drug effects
  • Streptococcus oralis / drug effects
  • Streptococcus sanguis / drug effects
  • Titanium / chemistry*
  • Titanium / pharmacology*
  • beta-Defensins / metabolism

Substances

  • Anti-Infective Agents
  • DEFB103A protein, human
  • Peptides
  • beta-Defensins
  • Titanium